Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SSPFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Siriuspoint's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Siriuspoint's regulatory disclosures and financial reporting.
SiriusPoint Ltd Chief Financial Officer James J. McKinney reported a routine tax-related share disposition. On May 31, 2026, 3,648 Common Shares were withheld at $21.35 per share to cover current tax liabilities tied to vesting of restricted share units. This was not an open-market sale. After the withholding, McKinney directly holds 50,711 Common Shares, which the disclosure notes includes restricted shares.
SiriusPoint Ltd Chief Financial Officer James J. McKinney reported a routine tax-related share disposition. On May 31, 2026, 3,648 Common Shares were withheld at $21.35 per share to cover current tax liabilities tied to vesting of restricted share units. This was not an open-market sale. After the withholding, McKinney directly holds 50,711 Common Shares, which the disclosure notes includes restricted shares.
Robart Jason reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Jason Robart reported an equity grant of 5,903 Common Shares at $23.29 per share. This is a compensation-related award, not an open-market purchase. Following the grant, he holds 97,303 Common Shares directly.
The holding total includes restricted shares that are scheduled to vest in full on May 30, 2027, subject to his continued service as a director. This filing reflects routine director compensation and does not indicate discretionary buying or selling in the market.
Robart Jason reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Jason Robart reported an equity grant of 5,903 Common Shares at $23.29 per share. This is a compensation-related award, not an open-market purchase. Following the grant, he holds 97,303 Common Shares directly.
The holding total includes restricted shares that are scheduled to vest in full on May 30, 2027, subject to his continued service as a director. This filing reflects routine director compensation and does not indicate discretionary buying or selling in the market.
Mahmud Mehdi reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Mahmud Mehdi received a grant of 5,903 Common Shares at a reference price of $23.29 per share. This award increases his direct holdings to 123,558 Common Shares.
The position includes restricted shares scheduled to vest in full on May 30, 2027, conditional on his continued service as a director.
Mahmud Mehdi reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Mahmud Mehdi received a grant of 5,903 Common Shares at a reference price of $23.29 per share. This award increases his direct holdings to 123,558 Common Shares.
The position includes restricted shares scheduled to vest in full on May 30, 2027, conditional on his continued service as a director.
Masojada Bronislaw Edmund reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Bronislaw Edmund Masojada received an equity award of 5,903 Common Shares, valued at $23.29 per share. This was a grant, not an open-market purchase, and increased his direct holdings to 65,727 Common Shares. The position includes restricted shares that vest in full on May 30, 2027, subject to his continued service as a director.
Masojada Bronislaw Edmund reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Bronislaw Edmund Masojada received an equity award of 5,903 Common Shares, valued at $23.29 per share. This was a grant, not an open-market purchase, and increased his direct holdings to 65,727 Common Shares. The position includes restricted shares that vest in full on May 30, 2027, subject to his continued service as a director.
Ludlow Sharon M reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Sharon M. Ludlow reported receiving a grant of 5,903 Common Shares of the company on May 29, 2026, recorded at $23.29 per share. This is a compensation-related award, not an open‑market purchase.
After this grant, Ludlow directly holds 160,693 Common Shares, which include restricted shares. The footnotes state that some of these restricted shares will vest in full on May 30, 2027, if she continues to serve as a director through that date.
Ludlow Sharon M reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Sharon M. Ludlow reported receiving a grant of 5,903 Common Shares of the company on May 29, 2026, recorded at $23.29 per share. This is a compensation-related award, not an open‑market purchase.
After this grant, Ludlow directly holds 160,693 Common Shares, which include restricted shares. The footnotes state that some of these restricted shares will vest in full on May 30, 2027, if she continues to serve as a director through that date.
Hudson Martin Peter reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Hudson Martin Peter received an equity award of 5,903 Common Shares at $23.29 per share. This grant increases his direct holdings to 9,601 Common Shares. The total includes restricted shares scheduled to vest in full on May 30, 2027, contingent on his continued service as a director.
Hudson Martin Peter reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Hudson Martin Peter received an equity award of 5,903 Common Shares at $23.29 per share. This grant increases his direct holdings to 9,601 Common Shares. The total includes restricted shares scheduled to vest in full on May 30, 2027, contingent on his continued service as a director.
SiriusPoint Ltd director Susan Lee Cross reported an equity award of 5,903 Common Shares on May 29, 2026. The shares were valued at $23.29 per share at grant and represent a compensation-related acquisition, not an open-market purchase.
After this grant, Cross directly holds 23,887 Common Shares, which include restricted shares. A portion of these restricted shares will vest in full on May 30, 2027, subject to her continued service as a director.
SiriusPoint Ltd director Susan Lee Cross reported an equity award of 5,903 Common Shares on May 29, 2026. The shares were valued at $23.29 per share at grant and represent a compensation-related acquisition, not an open-market purchase.
After this grant, Cross directly holds 23,887 Common Shares, which include restricted shares. A portion of these restricted shares will vest in full on May 30, 2027, subject to her continued service as a director.
Purtill Sabra R. reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Sabra R. Purtill received a grant of 5,903 common shares as equity compensation. The shares are restricted and vest in full on May 30, 2027, subject to her continued service as a director. Following this award, she directly holds 5,903 common shares.
Purtill Sabra R. reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Sabra R. Purtill received a grant of 5,903 common shares as equity compensation. The shares are restricted and vest in full on May 30, 2027, subject to her continued service as a director. Following this award, she directly holds 5,903 common shares.
SiriusPoint Ltd. reported results of its 2026 annual general meeting of shareholders held on May 20, 2026. Shareholders elected two Class I directors, Susan L. Cross and Sabra R. Purtill, each to serve until the 2029 annual meeting, with strong support in the “for” votes.
Shareholders also approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers as disclosed in the proxy statement. They further approved the appointment of PricewaterhouseCoopers LLP as independent auditor through the 2027 annual meeting and authorized the board’s Audit Committee to set the auditor’s remuneration.
In addition, shareholders approved the SiriusPoint SharePlan, which had been adopted by the board on February 12, 2026, subject to shareholder approval. The company noted that certain voting limitations in its Bye-laws were not applied in tabulating votes for this meeting.
SiriusPoint Ltd. reported results of its 2026 annual general meeting of shareholders held on May 20, 2026. Shareholders elected two Class I directors, Susan L. Cross and Sabra R. Purtill, each to serve until the 2029 annual meeting, with strong support in the “for” votes.
Shareholders also approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers as disclosed in the proxy statement. They further approved the appointment of PricewaterhouseCoopers LLP as independent auditor through the 2027 annual meeting and authorized the board’s Audit Committee to set the auditor’s remuneration.
In addition, shareholders approved the SiriusPoint SharePlan, which had been adopted by the board on February 12, 2026, subject to shareholder approval. The company noted that certain voting limitations in its Bye-laws were not applied in tabulating votes for this meeting.
SiriusPoint Ltd reports that Donald Smith & Co., Inc. beneficially owns 9,486,460 shares of common stock, representing 8.11% of the class as of 03/31/2026. The filing attributes sole voting power of 9,156,827 shares and sole dispositive power of 9,398,217 shares to Donald Smith & Co., Inc., and shows 88,243 shares held by DSCO Value Fund, L.P.
The schedule notes these holdings are reported by the investment adviser on behalf of institutional clients and states no single client holds more than 5% of the class. The schedule is signed by Richard L. Greenberg as CEO and Co-CIO on 05/13/2026.
SiriusPoint Ltd reports that Donald Smith & Co., Inc. beneficially owns 9,486,460 shares of common stock, representing 8.11% of the class as of 03/31/2026. The filing attributes sole voting power of 9,156,827 shares and sole dispositive power of 9,398,217 shares to Donald Smith & Co., Inc., and shows 88,243 shares held by DSCO Value Fund, L.P.
The schedule notes these holdings are reported by the investment adviser on behalf of institutional clients and states no single client holds more than 5% of the class. The schedule is signed by Richard L. Greenberg as CEO and Co-CIO on 05/13/2026.